The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
Open accessAbstract
It was the aim of this study to determine whether FFA inhibit insulin-stimulated whole body glucose uptake and utilization in patients with non-insulin-dependent diabetes. We performed five types of isoglycemic (approximately 11mM) clamps: (a) with insulin; (b) with insulin plus fat/heparin; (c) with insulin plus glycerol; (d) with saline; (e) with saline plus fat/heparin and two types of euglycemic (approximately 5mM) clamps: (a) with insulin; (b) with insulin plus fat/heparin. During these studies, we determined rates of glucose uptake, glycolysis (both with 3[3H] glucose), glycogen synthesis (determined as glucose uptake minus glycolysis), carbohydrate oxidation (by indirect calorimetry) and nonoxidative glycolysis (determined as glycolysis minus carbohydrate oxidation). Fat/heparin infusion did not affect basal glucose uptake, but inhibited total stimulated (insulin stimulated plus basal) glucose uptake by 40-50% in isoglycemic and in euglycemic patients at plasma FFA concentration of approximately 950 and approximately 550 microM, respectively. In isoglycemic patients, the 40-50% inhibition of total stimulated glucose uptake was due to near complete inhibition of the insulin-stimulated part of glucose uptake. Proportional inhibition of glucose uptake, glycogen synthesis, and glycolysis suggested a major FFA-mediated defect involving glucose transport and/or phosphorylation. In summary, fat produced proportional inhibitions of insulin-stimulated glucose uptake and of intracellular glucose utilization. We conclude, that physiologically elevated levels of FFa could potentially be responsible for a large part of the peripheral insulin resistance in patients with non-insulin-dependent diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Self-citationThe Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Automated and Manual Direct Methods for the Determination of Blood Urea
Marsh, W. H., Fingerhut, B., & Miller, H. (1965) · Clinical Chemistry · doi:10.1093/clinchem/11.6.624 · Cited by 1,092
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Research works printed but not linked: 2
- Harris, G., G. R. Faloona, and R. H. Unger. 1979. Glucagon. In Methods of Hormone Radioimmunoassay. B. M. Jaff and H. R. Behrmann, editors. Aca- demic Press, Inc., New York, NY. 643-656.
- Eggstein, M., and E. Kuhlmann. 1974. Triglyceride and glycerol. Determi- nation after alkaline hydrolysis. In Methods of Enzymatic Analysis. H. U. Berg- meyer, J. Bergmeyer, and M. Grabl, editors. Academic Press, Inc., New York. 1825-1831.
Cited by
Sorted by citations
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Self-citationBoden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Self-citationActivation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 974
Boden, G. H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 852
Self-citationObesity, insulin resistance and free fatty acids
Boden, G. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283444b09 · Cited by 848
Self-citationPathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647
Boden, G., Lebed, B., Schatz, M., Homko, C., & Lemieux, S. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1612 · Cited by 597
Self-citationFatty acids, lipotoxicity and insulin secretion
McGarry, J., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 548
Boden, G., She, P., Mozzoli, M., Cheung, P., Gumireddy, K., Reddy, P., Xiang, X., Luo, Z., & Ruderman, N. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3458 · Cited by 528
Self-citationOxidative Capacity, Lipotoxicity, and Mitochondrial Damage in Type 2 Diabetes
Schrauwen, P., & Hesselink, M. K. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1412 · Cited by 408
Kelley, D. E., & Goodpaster, B. H. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.933 · Cited by 411
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1640 · Cited by 404
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Xu, J., & Zou, M. (2009) · Circulation · doi:10.1161/circulationaha.108.835223 · Cited by 360
Benoit, S. C., Kemp, C. J., Elias, C. F., Abplanalp, W., Herman, J. P., Migrenne, S., Lefevre, A.-L., Cruciani-Guglielmacci, C., Magnan, C., Yu, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36714 · Cited by 351
Insulin resistance in obesity: an overview of fundamental alterations
Barazzoni, R., Cappellari, G. G., Ragni, M., & Nisoli, E. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0481-6 · Cited by 383
Fat Depots, Free Fatty Acids, and Dyslipidemia
Ebbert, J. O., & Jensen, M. D. (2013) · Nutrients · doi:10.3390/nu5020498 · Cited by 355
Oleate Reverses Palmitate-induced Insulin Resistance and Inflammation in Skeletal Muscle Cells
Coll, T., Eyre, E., Rodríguez-Calvo, R., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708700200 · Cited by 347
Link between obesity and type 2 diabetes
Golay, A., & Ybarra, J. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.010 · Cited by 301
Clarke, S. D. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500000969 · Cited by 295
Martins, A. R., Nachbar, R. T., Gorjão, R., Vinolo, M. A. R., Festuccia, W. T., Lambertucci, R. H., Cury‐Boaventura, M. F., Silveira, L. R., Curi, R., & Hirabara, S. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-30 · Cited by 306
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., HEJNA, J. M., Chaudhuri, A., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 285
Sex dimorphism and depot differences in adipose tissue function
White, U. A., & Tchoukalova, Y. D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.006 · Cited by 296
Fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver
Boden, G. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0031-x · Cited by 276
Self-citationInter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
San-Millán, I., & Brooks, G. A. (2018) · Sports Medicine · doi:10.1007/s40279-017-0751-x · Cited by 264
Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260
Free fatty acids, insulin resistance, and type 2 diabetes mellitus
Boden, G. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99220.x · Cited by 246
Self-citationPathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review
Bjornstad, P., & Eckel, R. H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1101-6 · Cited by 262
Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle
Koonen, D. P. Y., Glatz, J. F. C., Bonen, A., & Luiken, J. J. F. P. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.018 · Cited by 243
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
Giorgino, F., Laviola, L., & Eriksson, J. W. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01385.x · Cited by 230
Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
Brehm, A., Krssak, M., Schmid, A. I., Nowotny, P., Waldhäusl, W., & Roden, M. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1286 · Cited by 239
Winer, N., & Sowers, J. R. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004263017 · Cited by 231
Interaction between free fatty acids and glucose metabolism
Boden, G. H. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00014 · Cited by 224
Self-citationThe Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis
Ginsberg, H. N., & Huang, L.-S. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700505 · Cited by 209
Kim, S. P., Ellmerer, M., Citters, G. W. V., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2453 · Cited by 195
Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G. W., Mandarino, L. J., Shulman, G. I., & DeFronzo, R. A. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3148 · Cited by 181
Pigment Epithelium-Derived Factor Contributes to Insulin Resistance in Obesity
Crowe, S., Wu, L. E., Economou, C., Turpin-Nolan, S. M., Matzaris, M., Hoehn, K. L., Hevener, A. L., James, D. E., Duh, E. J., & Watt, M. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.06.001 · Cited by 179
Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
PATHOGENESIS OF TYPE 2 DIABETES
Boden, G. H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70216-4 · Cited by 173
Self-citationLipids and Glucose in Type 2 Diabetes
Boden, G. H., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2253 · Cited by 168
Self-citationAdipocyte triglyceride lipase expression in human obesity
Steinberg, G. R., Kemp, B. E., & Watt, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00235.2007 · Cited by 166
Regulation and function of triacylglycerol lipases in cellular metabolism
Watt, M. J., & Steinberg, G. R. (2008) · Biochemical Journal · doi:10.1042/bj20080305 · Cited by 165
Turpin, S. M., Lancaster, G. I., Darby, I., Febbraio, M. A., & Watt, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2006 · Cited by 164
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
Naz, R., Saqib, F., Awadallah, S. M., Wahid, M., Latif, M. F., Iqbal, I., & Mubarak, M. S. (2023) · Molecules · doi:10.3390/molecules28103996 · Cited by 178
Lundgren, M., Burén, J., Ruge, T., Myrnäs, T., & Eriksson, J. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031157 · Cited by 163
Goodpaster, B. H., & Kelley, D. E. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0086-2 · Cited by 155
Muscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & den Bosch, J. D. V. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 163
Clerk, L. H., Rattigan, S., & Clark, M. G. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1138 · Cited by 158
Free Fatty Acids—The Link Between Obesity and Insulin Resistance
Boden, G. H. (2001) · Endocrine Practice · doi:10.4158/ep.7.1.44 · Cited by 155
Self-citationColl, T., Jové, M., Rodríguez‐Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 152
Free fatty acids FFA a link between obesity and insulin resistance
Boden, G. H. (1998) · Frontiers in bioscience · doi:10.2741/a272 · Cited by 148
Self-citationYi, L., He, J., Liang, Y., Yuan, D., & Chau, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.043 · Cited by 148
PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes
Martin, G., Schoonjans, K., Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00315-8 · Cited by 138
Bonen, A., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., & Heigenhauser, G. J. F. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803212 · Cited by 146
Pirro, M., Mauriège, P., Tchernof, A., Cantin, B., Dagenais, G. R., Després, J., & Lamarche, B. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00588-3 · Cited by 137
Hafidi, M. E., Pérez, I., Zamora, J., Soto, V., Carvajal‐Sandoval, G., & Baños, G. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00159.2004 · Cited by 136
Jové, M., Planavila, A., Laguna, J. C., & Vázquez-Carrera, M. (2005) · Endocrinology · doi:10.1210/en.2004-1560 · Cited by 133
Pancreatic Function, Type 2 Diabetes, and Metabolism in Aging
Gong, Z., & Muzumdar, R. H. (2012) · International Journal of Endocrinology · doi:10.1155/2012/320482 · Cited by 138
Exercise therapy in Type 2 diabetes
Praet, S., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 135
Metabolic Adaptations to Dexamethasone‐Induced Insulin Resistance in Healthy Volunteers
Nicod, N., Giusti, V., Besse, C., & Tappy, L. (2003) · Obesity Research · doi:10.1038/oby.2003.90 · Cited by 125
Insulin resistance – a common link between type 2 diabetes and cardiovascular disease
Lebovitz, H. E. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00521.x · Cited by 125
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1999.0784 · Cited by 124
Nugent, C., Prins, J. B., Whitehead, J. P., Wentworth, J. M., Chatterjee, K., & O’Rahilly, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009817200 · Cited by 116
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 136
Gonzalez, R., Perry, R. L. S., Gao, X., Gaidhu, M. P., Tsushima, R. G., Ceddia, R. B., & Unniappan, S. (2011) · Endocrinology · doi:10.1210/en.2010-1471 · Cited by 114
Kim, J. H., Cho, H. T., & Kim, Y. J. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0262 · Cited by 111
Smith, G. I., Yoshino, J., Kelly, S. C., Reeds, D. N., Okunade, A., Patterson, B. W., Klein, S., & Mittendorfer, B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.047 · Cited by 111
Daly, M., Vale, C., Walker, M., Littlefield, A., Kg, A., & Mathers, J. C. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.6.1186 · Cited by 111
Adipose tissue as an endocrine organ
Prins, J. B. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0222 · Cited by 121
Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
Navarro‐González, J. F., & Fernández, C. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.179 · Cited by 110
Bajaj, M., Suraamornkul, S., Kashyap, S., Cusi, K., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0224 · Cited by 109
Apparent diffusion tensor measurements in myelin-deficient rat spinal cords
Gulani, V., WEBB, A. G., Duncan, I. D., & Lauterbur, P. C. (2001) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200102)45:2 · Cited by 250
Free fatty acids, insulin resistance, and pregnancy
Sivan, E., & Boden, G. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0024-y · Cited by 105
Self-citationUpdating the effects of fatty acids on skeletal muscle
Silveira, L. R., Fiamoncini, J., Hirabara, S. M., Procópio, J., Cambiaghi, T. D., Pinheiro, C. H. D. J., Lopes, L. R., & Curi, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21514 · Cited by 106
Kelley, D. E., Williams, K. V., Price, J. C., McKolanis, T. M., Goodpaster, B. H., & Thaete, F. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8027 · Cited by 103
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Pinnamaneni, S. K., Southgate, R. J., Febbraio, M. A., & Watt, M. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0427-9 · Cited by 100
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, É., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 101
Protection From Obesity and Insulin Resistance in Mice Overexpressing Human Apolipoprotein C1
Jong, M. C., Voshol, P. J., Muurling, M., Dahlmans, V. E. H., Romijn, J. A., Pijl, H., & Havekes, L. M. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2779 · Cited by 98
Fabbrini, E., DeHaseth, D., Deivanayagam, S., Mohammed, B. S., Vitola, B. E., & Klein, S. (2008) · Obesity · doi:10.1038/oby.2008.494 · Cited by 94
Coll, T., Álvarez-Guardia, D., Barroso, E., Gómez-Foix, A. M., Palomer, X., Laguna, J. C., & Vázquez-Carrera, M. (2010) · Endocrinology · doi:10.1210/en.2009-1211 · Cited by 90
Management of diabesity: Current concepts
Michaelidou, M., Pappachan, J. M., & Jeeyavudeen, M. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i4.396 · Cited by 97
Free fatty acids and type 2 diabetes mellitus
Wyne, K. L. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.004 · Cited by 90
Watt, M. J., Hevener, A. L., Lancaster, G. I., & Febbraio, M. A. (2006) · Endocrinology · doi:10.1210/en.2005-1074 · Cited by 92
Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden, G., & Chen, X. (1999) · Diabetes · doi:10.2337/diabetes.48.3.577 · Cited by 91
Self-citationBasu, R., Schwenk, W. F., & Rizza, R. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2003 · Cited by 87
Gilbert, M. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13614 · Cited by 90
Shah, P., Vella, A. V., Basu, A., Basu, R., Adkins, A., Schwenk, W. F., Johnson, C. M., Nair, K. S., Jensen, M. D., & Rizza, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.301 · Cited by 84
Schuster, D. P., & Duvuuri, V. (2002) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/s0891-8422(03)00082-x · Cited by 94
Free Fatty Acids and Insulin Resistance during Pregnancy
Sivan, E., Homko, C. J., Whittaker, P. G., Reece, E. A., Chen, X., & Boden, G. H. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4927 · Cited by 90
Self-citationColitti, M., Stefanon, B., Gabai, G., Gelain, M. E., & Bonsembiante, F. (2019) · Antioxidants · doi:10.3390/antiox8010028 · Cited by 78
Effects of Free Fatty Acids on Glucose Uptake and Utilization in Healthy Women
Homko, C. J., Cheung, P., & Boden, G. H. (2003) · Diabetes · doi:10.2337/diabetes.52.2.487 · Cited by 78
Self-citationTroglitazone Antagonizes Metabolic Effects of Glucocorticoids in Humans
Willi, S. M., Kennedy, A., Wallace, P., Ganaway, E., Rogers, N. L., & Garvey, W. T. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2895 · Cited by 77
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · PubMed · doi:10.1097/01.hjr.0000060840.46106.ea · Cited by 77
Benthem, L., Keizer, K., Wiegman, C., de Boer, S. F., STRUBBE, J. H., Steffens, A. B., Kuipers, F., & Scheurink, A. J. W. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.6.e1286 · Cited by 77
Metadata
- Authors
- Boden, G., & Chen, X.
- Affiliations
- Temple University (US)
- ORCID
- Chen, X
- Venue
- Journal of Clinical Investigation
- Published
- 1995-09-01
- Volume
- 96
- Issue
- 3
- Pages
- 1261-1268
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC185747
- OpenAlex
- W2115830695
- Cited by
- 344
- References
- 39
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 6 · 2015: 13 · 2014: 8 · 2013: 9 · 2012: 14
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5r01ag007988-10)
- National Institute on Aging (R01-AG07988)
- National Center for Research Resources (M01RR000349, RR-00349)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- free fatty acids, insulin resistance, type 2 diabetes, insulin-stimulated glucose uptake, glucose utilization, glucose transport, glycogen synthesis, glycolysis, carbohydrate oxidation, heparin, fat infusion
- MeSH terms
- Aged, Analysis of Variance, Blood Glucose, Diabetes Mellitus, Type 2, Emulsions, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Female, Glucagon, Glucose, Heparin, Humans, Infusions, Intravenous, Insulin, Isophane, Male, Middle Aged, Phospholipids, Recombinant Proteins, Safflower Oil, Soybean Oil, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review